Enfermedad valvular mitral y embarazo: una amenaza latente

Contenido principal del artículo

Evert Jiménez Cotes
Andrés Zapata Cárdenas

Resumen

La enfermedad valvular mitral durante el embarazo supone un riesgo tanto para las maternas como para el feto. Esta lesión valvular puede causar limitaciones físicas graves e, incluso, la muerte. Debido a que el diagnóstico se hace durante la gestación hasta en el 50% de los casos, aumenta la probabilidad de un resultado adverso. El manejo clínico implica un gran reto debido a que los cambios hemodinámicos durante el embarazo, parto y post-parto, representan riesgos únicos para este grupo de pacientes, lo que puede provocar descompensación clínica como insuficiencia cardiaca, arritmias y la muerte materna.

Palabras clave:
enfermedades de las válvulas cardíacas embarazo; complicaciones del embarazo anticoagulantes

Referencias

Thilén U, Olsson SB. Pregnancy and heart disease: a review. Eur J Obstet Gynecol Reprod Biol. 1997;75:43–50.

Soler Soler J, Galve E. Valve disease, worldwide perspective of valve disease. Heart. 2000;83(6):721-5.

Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21.

McFaul PB, Dornan JC, Lamki H, Boyle D. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol. 1988; 95: 861-867.

Roeder HA, Kuller JA, Barker PC, James AH. Maternal valvular heart disease in pregnancy. Obstet Gynecol Surv. 2011;66(9):561-71.

Fennira S, Rejeb MA, Ellouze Y, Khaldi H, Ouertani W, Tellili S, et al. Heart diseases in pregnant women. Tunis Med. 2008 Jun;86(6):584-90.

Burlew BS. Managing the pregnant patient with heart disease. Clin Cardiol.1990; 13(11):757-62.

Reimold SC, Rutherford JD. Clinical practice. Valvular heart disease in pregnancy. N Engl J Med. 2003;349(1):52-9.

Brady K, Duff P. Rheumatic heart disease in pregnancy. Clin Obstet Gynecol. 1989;32(1): 21-40

Van Oppen AC, Van der Tweel I, Alsbach GP, Heethaar RM, Bruinse HW. A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet Gynecol. 1996 Jul;88(1):40-6.

Davison JM. Kidney function in pregnant women. Am J Kidney Dis. 1987; 9:248-52.

Tornos P. Valvular heart disease in women. Rev Esp Cardiol. 2006 Aug;59(8):832-6.

Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256(4 Pt 2):H1060-5.

Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989;160:95–100.

Pieper PG, Balci A, Van Dijk AP. Pregnancy in women with prosthetic heart valves. Neth Heart J. 2008 Dec;16(12):406-11

Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Sep 23;52(13):e1-142

Hugenholtz PG, Ryan TJ, Stein SW, Belmann WH. The spectrum of pure mitral stenosis: hemodynamic studies in relation to clinical disability. Am J Cardiol. 1962;10:773– 84

Gorlin R. The mechanism of the signs and symptoms of mitral valve disease. Br Heart J. 1954;16:375– 80.

De Andrade J, Maldonado M, Pontes Jr S, Regina Elmec A, Eduardo M R De Sousa J. [The role of mitral valve balloon valvuloplasty in the treatment of rheumatic mitral valve stenosis during pregnancy]. Rev Esp Cardiol. 2001;54(5):573-9

Davies GA, Herbert WN. Acquired heart disease in pregnancy. J Obstet Gynaecol Can. 2007;29(6):507-9

Thorne SA. Pregnancy in heart disease. Heart. 2004;90:450-6.

Siva A, Shah AM. Moderate mitral stenosis in pregnancy: the haemodynamic impact of diuresis. Heart. 2005 Jan;91(1):e3.

Palacios I, Block PC, Brandi S, Blanco P, Casal H, Pulido JI, et al. Percutaneous balloon valvotomy for patients with severe mitral stenosis. Circulation. 1987;75: 78-784.

Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol. 2005;46:223–230.

Rita F, Nelson S. Gender and valvular surgery. J Thorac Cardiovasc Surg. 2004;127:1-3.

Bhatla N, Lal S, Behera G, Kriplani A, Mittal S, Agarwal N, et al. Cardiac disease in pregnancy. Int J Gynaecol Obstet. 2003 Aug;82(2):153-9.

Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease. Rev Esp Cardiol. 2007 Jun;60(6):1e-50e.

Vasu S, Stergiopoulos K. Valvular heart disease in pregnancy. Hellenic J Cardiol. 2009 NovDec;50(6):498-510.

Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B Streptococcal disease. Atlanta, GA: CDC; 2010.

Hawkins JA, Paape KL, Adkins TP, Shaddy RE, Gay WA Jr. Extracorporeal circulation in the fetal lamb. Effects of hypothermia and perfusion rate. J Cardiovasc Surg (Torino). 1991 MayJun;32(3):295-300.

Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J. 2003 Apr;24(8):761-81.

Henriquez DD, Roos-Hesselink JW, Schalij MJ, Klautz RJ, Helmerhorst FM, de Groot CJ. Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome. Cochrane Database Syst Rev. 2011 May 11;(5):CD008128

Esteves CA, Braga SN, Andrade J, Meneghelo ZM, Ramos AI, Lira NG et al. Percutaneous mitral valvotomy: immediate results and impact on fetal outcome. Circulation. 1994; 90: I-65.

Hameed AB, Mehra A, Rahimtoola SH. The role of catheter balloon commissurotomy for severe mitral stenosis in pregnancy. Obstet Gynecol. 2009 Dec;114(6):1336-40.

Zitnik RS, Brandenburg RO, Sheldon R, Wallace RB. Pregnancy and open-heart surgery. Circulation. 1969 May; 39(5 Suppl 1):I257-62.

Pomini F, Mercogliano D, Cavalletti C, Caruso A, Pomini P. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg. 1996 Jan;61(1):259-68.

Lin TY, Chiu KM, Shieh JS, Chu SH. Emergency redo mitral valve replacement in a pregnant woman at third trimester: case report and literature review. Circ J. 2008 Oct;72(10):1715-7.

Patel A, Asopa S, Tang AT, Ohri SK. Cardiac surgery during pregnancy. Tex Heart Inst J. 2008;35(3):307-12.

Stephen SJ. Changing patterns of mitral stenosis in childhood and pregnancy in Sri-Lanka. J Am Coll Cardiol. 1992; 19: 1276-1284.

Pavankumar P, Venugopal P, Kaul U, Iyer KS, Das B, Sampathkumar A, et al. Closed mitral valvotomy during pregnancy. A 20-year experience. Scand J Thorac Cardiovasc Surg. 1988;22(1):11-5.

Danik S, Fuster V. Anticoagulation in pregnant women with prosthetic heart valves. Mt Sinai J Med. 2004 Oct;71(5):322-9.

McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res. 2011 Feb;127.

McLintock C, North RA, White HD. Prosthetic heart valves and pregnancy. Circulation. 2003;108(23):e159-60.

Martinez-Diaz JL. Valvular heart disease in pregnancy: a review of the literature. Bol Asoc Med. 2008;100(4):55-9.

Akpinar O. Pregnancy and heart valve disease. Anadolu Kardiyol Derg. 2009; 9 Suppl 1:25-34.

Regitz-Zagrosek V, Seeland U, Geibel-Zehender A, Gohlke-Bärwolf C, Kruck I, Schaefer C. Cardiovascular diseases in pregnancy. Dtsch Arztebl Int. 2011;108(16):267-73.

Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol. 2009;104(9):1259-63.

Wong V, Cheng KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy. Am J Med Genet. 1993;45: 17.21

Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy. Circulation. 2003;107(9):1240-6.

Khamooshi AJ, Kashfi F, Hoseini S, Tabatabaei MB, Javadpour H, Noohi F. Anticoagulation for prosthetic heart valves in pregnancy. Is there an answer?. Asian Cardiovasc Thorac Ann. 2007 Dec;15(6):493-6.

Huisman MV. Further issues with new oral anticoagulants. Curr Pharm Des.2010;16(31):3487-9.

Jeejeebhoy FM. Prosthetic heart valves and management during pregnancy. Can Fam Physician. 2009; 55(2):155-7.

Bjork VO, Henze A. Management of thrombo-embolism after aortic valve replacement with the Bjork-Shiley tilting disc valve: medicamental prevention with dicumarol in comparison with dipyridamole-acetylsalicylic acid; surgical treatment of prosthetic thrombosis. Scand J Thorac Cardiovasc Surg. 1975; 9: 183-191.

Neal JM, Bernards CM, Hadzic A, Hebl JR, Hogan QH, Horlocker TT, et al. ASRA Practice Advisory on Neurologic Complications in Regional Anesthesia and Pain Medicine. Reg Anesth Pain Med. 2008; 33:404–415.

Detalles del artículo

Biografía del autor/a

Evert Jiménez Cotes, Universidad Pontificia Bolivariana

Estudiante de pregrado, monitor docente de Biología molecular, Facultad de Medicina. Universidad Pontificia Bolivariana. Medellín, Colombia

Andrés Zapata Cárdenas, Universidad Pontificia Bolivariana

Médico, Residente Medicina Interna. Universidad Pontificia Bolivariana. Medellín, Colombia.